Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
307.00
+3.00 (0.99%)
Aug 7, 2025, 3:30 PM JST
Wakamoto Pharmaceutical Market Cap
Wakamoto Pharmaceutical has a market cap or net worth of 10.58 billion as of August 6, 2025. Its market cap has increased by 27.20% in one year.
Market Cap
10.58B
Enterprise Value
n/a
Revenue
9.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
307.00
Market Cap Chart
Since August 18, 1993, Wakamoto Pharmaceutical's market cap has decreased from 27.21B to 10.58B, a decrease of -61.13%. That is a compound annual growth rate of -2.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 10.58B | 35.71% |
Dec 30, 2024 | 7.79B | 5.16% |
Dec 29, 2023 | 7.41B | -4.05% |
Dec 30, 2022 | 7.72B | -28.85% |
Dec 30, 2021 | 10.86B | 28.40% |
Dec 30, 2020 | 8.45B | -11.64% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 12.11T |
Daiichi Sankyo Company | 6,600.46B |
Takeda Pharmaceutical Company | 6,590.05B |
HOYA Corporation | 6,191.93B |
Otsuka Holdings | 3,913.98B |
Terumo | 3,759.91B |
Astellas Pharma | 2,786.62B |
Shionogi & | 2,166.95B |